Pharmacokinetics of colon-specific pH and time-dependent flurbiprofen tablets

  • Sateesh Kumar VemulaEmail author
  • Prabhakar Reddy Veerareddy
  • Venkat Ratnam Devadasu
Original Paper


Present research deals with the development of compression-coated flurbiprofen colon-targeted tablets to retard the drug release in the upper gastro intestinal system, but progressively release the drug in the colon. Flurbiprofen core tablets were prepared by direct compression method and were compression coated using sodium alginate and Eudragit S100. The formulation is optimized based on the in vitro drug release study and further evaluated by X-ray imaging and pharmacokinetic studies in healthy humans for colonic delivery. The optimized formulation showed negligible drug release (4.33 ± 0.06 %) in the initial lag period followed by progressive release (100.78 ± 0.64 %) for 24 h. The X-ray imaging in human volunteers showed that the tablets reached the colon without disintegrating in the upper gastrointestinal tract. The C max of colon-targeted tablets was 12,374.67 ng/ml at T max 10 h, where as in case of immediate release tablets the C max was 15,677.52 ng/ml at T max 3 h, that signifies the ability of compression-coated tablets to target the colon. Development of compression-coated tablets using combination of time-dependent and pH-sensitive approaches was suitable to target the flurbiprofen to colon.


Direct compression In vitro drug release Lag period pH sensitive Time dependent X-ray imaging 



The authors acknowledge FDC Limited, Mumbai, India and Matrix laboratories, Hyderabad, India for gift sample of Flurbiprofen, Sodium alginate and Eudragit S100. The authors also thank the Principal and Management, Jangaon Institute of Pharmaceutical Sciences for providing the facilities.

Conflict of interest

The authors report no conflicts of interest.


  1. Asghar LF, Chandran S (2006) Multiparticulate formulation approach to colon-specific drug delivery: current perspectives. J Pharm Sci 9:327–338Google Scholar
  2. Asghar LF, Chure CB, Chandran S (2009) Colon specific delivery of indomethacin: effect of incorporating pH sensitive polymers in xanthan gum compression coated Bases. AAPS Pharm Sci Tech 10:418–429CrossRefGoogle Scholar
  3. Ashford M, Fell J, Attwood D, Sharma H, Woodhead P (2003) An evaluation of pectin as a carrier for drug targeting to the colon. J Con Rel 26:213–220CrossRefGoogle Scholar
  4. Aurora J, Talwar N, Pathak V (2006) Colonic drug delivery challenges and opportunities-an overview. Eur Gastro Rev 1:1–6Google Scholar
  5. Chaudhary A, Tiwari N, Jain V, Singh R (2011) Microporous bilayer osmotic tablet for colon-specific delivery. Eur J Pharm Biopharm 78:134–140CrossRefPubMedGoogle Scholar
  6. Cheng G, Feng A, Zou M (2004) Time and pH dependent colon specific drug delivery for orally administered diclofencac sodium and 5-amino salicylic acid. World J Gastroenterol 10:1769–1774PubMedGoogle Scholar
  7. Chickpetty SM, Baswaraj R, Nanjwade BK (2010) Studies on development of novel combined time and pH dependent solventless compression coated delivery systems for colonic delivery of diclofenac sodium. Asian J Pharm Clin Res 3:110–113Google Scholar
  8. Chourasia MK, Jain SK (2003) Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharmaceut Sci 6:33–66Google Scholar
  9. Davaran S, Rashidi MR, Hashemi M (2001) Synthesis and characterization of methacrylic derivatives of 5-amino salicylic acid with pH-sensitive swelling properties. AAPS Pharm Sci Tech 2:1–6CrossRefGoogle Scholar
  10. El-Kamel AH, Abdel-Aziz AM, Fatani AJ, El-Subbagh HI (2008) Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment. Int J Pharm 358:248–255CrossRefPubMedGoogle Scholar
  11. Ghimire M, Hodges LA, Band J, Lindsay B, Mahony BO, McInnes FJ, Mullen AB, Stevens HNE (2011) Correlation between in vitro and in vivo erosion behaviour of erodible tablets using gamma scintigraphy. Eur J Pharm Biopharm 77:148–157CrossRefPubMedGoogle Scholar
  12. Gibaldi M, Perrier D (1990) Pharmacokinetics. Marcel Dekker, New YorkGoogle Scholar
  13. Grahnen A (1984) Design of bioavailability studies. Pharm Int 5:100–103Google Scholar
  14. Hashem FM, Shaker DS, Nasr M, Saad IE, Ragaey R (2011) Guar gum and hydroxy propyl methylcellulose compressed coated tablets for colonic drug delivery: in vitro and in vivo evaluation in healthy human volunteers. Drug Disc Ther 5:90–95CrossRefGoogle Scholar
  15. ICH Q1A (2003) Stability testing guidelines: stability testing of new drug substances and products. CPMP/ICH/380/95, 1–13Google Scholar
  16. Krishnaiah YSR, Satyanarayana S, Ramaprasad YV, Narasimharao S (1998) Evaluation of guar gum as a compression coat for drug targeting to colon. Int J Pharm 171:137–146CrossRefGoogle Scholar
  17. Krishnaiah YSR, Satyanarayana S, Dinesh Kumar B, Karthikeyan RS, Bhaskar P (2003a) In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets. Eur J Pharm Sci 19:355–362CrossRefPubMedGoogle Scholar
  18. Krishnaiah YSR, Raju VP, Kumar DB, Satyanarayana V, Karthikeyan RS, Bhaskar P (2003b) Pharmacokinetic evaluation of guar gum-based colon-targeted drug delivery systems of mebendazole in healthy volunteers. J Con Rel 88:95–103CrossRefGoogle Scholar
  19. Kumar M, Ali A, Kaldhone P, Shirode A, Kadam VJ (2010) Platform technologies for colon targeted drug delivery system. J Pharm Res 3:543–547Google Scholar
  20. Mandal S, Basu SK, Sa B (2010) Ca2+ ion cross-linked interpenetrating network matrix tablets of polyacrylamide-grafted-sodium alginate and sodium alginate for sustained release of diltiazem hydrochloride. Carb Polym 82:867–873CrossRefGoogle Scholar
  21. Maroni A, Zema L, Curto MDD, Foppoli A, Gazzaniga A (2012) Oral colon delivery of insulin with the aid of functional adjuvants. Adv Drug Del Rev 64:540–556CrossRefGoogle Scholar
  22. Mathews BR (1999) Regulatory aspects of stability testing in Europe. Drug Dev Ind Pharm 25:831–856CrossRefGoogle Scholar
  23. Orlu M, Cevher E, Araman A (2006) Design and evaluation of colon-specific drug delivery system containing flubiprofen microsponges. Int J Pharm 318:103–117CrossRefPubMedGoogle Scholar
  24. Philip AK, Dubey RK, Pathak K (2008) Optimizing delivery of flurbiprofen to the colon using a targeted prodrug approach. J Pharm Pharmacol 60:607–613CrossRefPubMedGoogle Scholar
  25. Shukla RK, Tiwari A (2012) Carbohydrate polymers: applications and recent advances in delivering drugs to the colon. Carb Polym 88:399–416CrossRefGoogle Scholar
  26. Sinha VR, Bhinje JR, Kumaria R, Kumar M (2006) Development of pulsatile systems for targeted drug delivery of celecoxib for prophylaxis of colorectal cancer. Drug Del 13:221–225CrossRefGoogle Scholar
  27. Talukder RM, Fassihi R (2008) Development and in vitro evaluation of a colon-specific controlled release drug delivery system. J Pharm Pharmacol 60:1297–1303CrossRefPubMedGoogle Scholar
  28. Tugcu-Demiroz F, Acarturk F, Takka S, Konus-Boyunaga O (2004) In vitro and In vivo evaluation of mesalazine-guar gum matrix tablets for colonic drug delivery. J Drug Targ 12:105–112CrossRefGoogle Scholar
  29. Valluru R, Siddaramaiah T, Pramod M (2008) Influence of natural polymer coating on novel colon targeting drug delivery system. J Mater Sci 19:2131–2136Google Scholar
  30. Veerareddy PR, Vemula SK (2012) Formulation, evaluation and pharmacokinetics of colon targeted pulsatile system of flurbiprofen. J Drug Targ 20:703–714CrossRefGoogle Scholar
  31. Vemula SK, Veerareddy PR (2009) Different approaches to design and evaluation of colon specific drug delivery systems. Int J Pharm Tech 1:1–35Google Scholar
  32. Vemula SK, Veerareddy PR (2011) Fast disintegrating tablets of flurbiprofen: formulation and characterization. Lat Am J Pharm 30:1135–1141Google Scholar
  33. Vemula SK, Veerareddy PR (2013) Formulation, evaluation and pharmacokinetics of ketorolac tromethamine time-dependent colon targeted drug delivery system. Exp Opin Drug Del 10(1):33–45CrossRefGoogle Scholar
  34. Vincent HL, Suman KM (2002) Drug delivery-oral colon-specific. In: Swarbick J, Boylan CJ (eds) Encyclopedia of pharmaceutical technology. Marcel Dekker, New York, pp 871–885Google Scholar
  35. Vyas SP, Roop KK (2006) Controlled drug delivery concepts and advances, 1st edn. Vallabh Prakashan, DelhiGoogle Scholar
  36. Wang X, Yu J, Tang X (2007) In vitro release and pharmacokinetics of flurbiprofen sustained-release capsules containing coated pellets. Asian J Pharm Sci 2:77–84Google Scholar
  37. Wu B, Shun N, Wei X, Lu Y, Wu W (2007a) Biphasic release of indomethacin from HPMC/pectin/calcium compression coated tablet: I. Characterization and mechanistic study. Eur J Pharm Biopharm 67:707–714CrossRefPubMedGoogle Scholar
  38. Wu B, Shun N, Wei X, Wu W (2007b) Characterization of 5-fluorouracil release from hydroxypropyl methylcellulose compression-coated tablets. Pharm Dev Tech 12:203–210CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Sateesh Kumar Vemula
    • 1
    • 2
    Email author
  • Prabhakar Reddy Veerareddy
    • 1
    • 3
  • Venkat Ratnam Devadasu
    • 1
  1. 1.Department of PharmaceuticsChaitanya College of Pharmacy Education and ResearchWarangalIndia
  2. 2.Department of PharmaceuticsJangaon Institute of Pharmaceutical SciencesWarangalIndia
  3. 3.College of Pharmacy Palamuru UniversityMahabubnagarIndia

Personalised recommendations